MyFinsight
Home
Blog
About
Net increase
(decrease) in cash and cash...
-$25,604K
(6.51%↑ Y/Y)
Share-based compensation
expense
$3,049K
(-46.06%↓ Y/Y)
Accounts payable,
accrued and other...
$1,832K
(163.70%↑ Y/Y)
Amortization of right-of-use
asset - operating
$101K
(-46.56%↓ Y/Y)
Prepaid and other assets
-$89K
(91.58%↑ Y/Y)
Depreciation and
amortization
$87K
(-62.98%↓ Y/Y)
Proceeds from the
issuance of class a common...
$4,000K
Proceeds from sale of
stock under the...
$203K
Net cash used in
operating activities
-$10,354K
(62.04%↑ Y/Y)
Net cash used in
investing activities
-$9,870K
(-31738.71%↓ Y/Y)
Net cash provided by
(used in) financing...
-$5,380K
(-6887.01%↓ Y/Y)
Canceled cashflow
$5,158K
Canceled cashflow
$4,203K
Net loss
-$15,346K
(50.99%↑ Y/Y)
Purchases of marketable
securities
$9,867K
Purchases of property and
equipment
$3K
(-90.32%↓ Y/Y)
Payment of issuance
costs associated with...
$9,583K
Lease liabilities
-$136K
(48.09%↑ Y/Y)
Accretion of discount on
marketable securities, net
$30K
Back
Back
Cash Flow
OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR)
source: myfinsight.com